Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
APPLIED THERAPEUTICS INVESTOR ALERT: Kaplan Fox Alerts Investors of a Class Action Deadline on February 18, 2024
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APPLIED THERAPEUTICS INVESTOR ALERT: Kaplan Fox Alerts Investors of a Class Action Deadline on February 18, 2024
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip
Via Stocktwits
Exposures Product Safety
Tickers ATRA VTI VXF
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Via Benzinga
Exposures Product Safety
Tickers AMD NVS OTLK RHHBY
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
Via TheNewswire.com
Exposures Product Safety
Tickers GOVX
FDA Bans Red Dye No. 3 Yet To Dismiss AATCLC Lawsuit To Have Menthol In Cigarettes Banned
Via PRLog
Topics Lawsuit
Exposures Financial Legal Product Safety
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
Via Benzinga
Exposures Product Safety
Tickers ABT COST GIS TAK
APLT SHAREHOLDER ALERT: Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT SHAREHOLDER ALERT: Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Celebrating 20 Years: Quality Home Inspections Reflect on Success and Future
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
Via NewMediaWire
Exposures Product Safety
Tickers GOVX
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials
Via Benzinga
Exposures Product Safety
Tickers VRTX
FDA Proposes Front-Of-Package Label To Improve Nutrition Transparency
Via Benzinga
Exposures Product Safety
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
Via Benzinga
Exposures Product Safety
Tickers BIIB
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Is a Ford Stock Turnaround on the Horizon?
Via MarketBeat
Topics Economy Electric Vehicles Government
Exposures Electric Vehicles Legal Political
Tickers F GM RIVN TSLA
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish
Via Stocktwits
Exposures Product Safety
Tickers VXF XXII
APLT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Applied Therapeutics, Inc. (APLT) and Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Applied Therapeutics, Inc. (APLT) and Lead Plaintiff Deadline on February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Sage Therapeutics Stock Eyes Best Day In 5 Years On Biogen’s Unsolicited Bid: Retail Piles In
Via Stocktwits
Exposures Product Safety
Tickers BIIB SAGE
What's Going On With 22nd Century Group Shares Monday?
Via Benzinga
Exposures Product Safety
Tickers XXII
BNI Clinics Explains TMS’s Safety for Adolescents
Via Press Advantage
Exposures Product Safety
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Highlights 2024 Achievements and Outlines Key 2025 Milestones
Via Investor Brand Network
Exposures Product Safety
Tickers CYBN
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
Via Newsfile
Exposures Product Safety
Tickers ADAP JPM
Tesla Recalls Over 239,000 Vehicles, Uber and Lyft Revamp Robotaxi Strategy, Warren Buffett-Backed BYD Launches Affordable EV And More: This Week In Mobility
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BRK BYDDF LYFT TSLA
Kessler Topaz Meltzer & Check, LLP Reminds APLT Investors of February 18, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kessler Topaz Meltzer &amp; Check, LLP Reminds APLT Investors of February 18, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY Announcement: Contact Kessler Topaz Meltzer &amp; Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc.
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
XRAY Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc.
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.